Related Experiment Video
Updated: Sep 18, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Catecholaminergic polymorphic ventricular tachycardia in children-incidence and trends in detection, presentation and
Nicholas Fitzgerald1, Claire Lawley2,3, Ansley Morrish4
1The Heart Centre for Children, The Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.
Insights
The birth rate for catecholaminergic polymorphic ventricular tachycardia (CPVT) diagnosed in childhood is approximately 1 in 65,000 live births. Recurrent cardiac events in CPVT patients were linked to poor adherence and beta-blocker monotherapy.
Area of Science:
- Pediatric Cardiology
- Genetics
- Epidemiology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare, inherited arrhythmia.
- Early diagnosis and management are crucial for preventing life-threatening cardiac events in children.
Purpose of the Study:
- To determine the birth rate of childhood-diagnosed CPVT.
- To analyze trends in CPVT presentation and management in pediatric patients.
- To identify factors associated with adverse outcomes in CPVT.
Main Methods:
- Retrospective cohort study of children diagnosed with CPVT (0-16 years) in New South Wales, Australia (2002-2021).
- Clinical data extraction and analysis for trends in diagnosis and management.
- Calculation of CPVT birth rate using birth year data.
Main Results:
- 32 children diagnosed with CPVT; 88% presented with symptoms, including cardiac arrest (62.5%).
- Genetic variants identified in 78% of cases.
- The birth rate of CPVT in childhood was 1 in 65,000 live births in NSW.
- 10% of patients experienced symptomatic cardiac events during follow-up, often linked to suboptimal adherence or beta-blocker monotherapy.
Conclusions:
- The incidence of CPVT diagnosed in childhood is approximately 1 in 65,000 live births.
- Suboptimal adherence and beta-blocker monotherapy (without flecainide) were associated with recurrent cardiac events in pediatric CPVT patients.
Objective:
To establish a birth rate for catecholaminergic polymorphic ventricular tachycardia (CPVT) diagnosed in childhood and observe trends in presentation and management.
Design:
Retrospective cohort study.
Setting:
The Inherited Arrhythmia Clinic at The Sydney Children's Hospitals Network, a paediatric tertiary referral network, New South Wales (NSW), Australia (2002-2021), where there are 86 000-97 000 live births/year.
Patients:
Children diagnosed with CPVT aged 0-16 years.
Interventions:
Clinical data were extracted and evaluated for trends. Using birth year data, the birth rate of CPVT detected in childhood was calculated.
Main Outcome Measures:
Birth rate of CPVT detected in childhood in NSW (with post hoc comparison to New Zealand), trends in diagnosis and management, and outcome at last follow-up.
Results:
32 children in NSW were diagnosed with CPVT between 2002 and 2021 (0-16 years, median 9 years, 14 (54%) female). Of these, 28 (88%) presented with symptoms (cardiac arrest 20/32, 62.5%) and four (12%) were identified through family screening. Relevant genetic variants were identified in 25/31 (78%). During follow-up (median 4.5 years), symptomatic cardiac events (death n=1) occurred in 10 (33%), largely related to suboptimal adherence or monotherapy beta blocker. In NSW, CPVT was diagnosed during childhood following 1 in 65 000 live births (95% CI 1 in 91 000 to 1 in 46 000). In New Zealand, the corresponding figure was 1 in 84 000 live births (95% CI 1 in 138 000 to 1 in 52 000).
Conclusions:
The rate of infants born who are later diagnosed with CPVT in childhood is approximately 1 in 65 000 live births. Suboptimal adherence and beta blocker therapy without flecainide appeared related to recurrent cardiac events.
More Related Videos
06:07Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
Published on: May 23, 2021
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Dysrhythmias V: Evaluating Dysrhythmias
Mechanism of Cardiac Arrhythmias